Image pharmaphorum Editor R&D Inside out – the coming of age of organ-on-a-chip technology Perhaps the most beautiful thing about pharmacology, and the healthcare industry at large, is the continued pursuit of new ideas and innovations. R&D Research & Development 2023 So, what does 2023 have in store for pharma R&D? Digital Tackling ongoing staffing burnout rates through AI-enabled p... The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows. Market Access Breaking through the forecasting fog - 3 trends that will im... As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future. Load more results
R&D Inside out – the coming of age of organ-on-a-chip technology Perhaps the most beautiful thing about pharmacology, and the healthcare industry at large, is the continued pursuit of new ideas and innovations.
Digital Tackling ongoing staffing burnout rates through AI-enabled p... The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows.
Market Access Breaking through the forecasting fog - 3 trends that will im... As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future.
News Rezzayo antifungal okayed as Candida auris rings alarm bells Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
